On March 3, 2026 (Tue) at 11:00 JST, our CEO/CSO, Tamaki, will take the stage as a finalist at XTC JAPAN 2026, the Japan round of the global deep tech startup competition Extreme Tech Challenge (XTC), co-organized by Gaiax Co., Ltd. and IT Farm Corporation.

In addition, MOLCURE will participate in JID 2026 by ASCII STARTUP, an exhibition and networking event held concurrently with XTC JAPAN 2026. Our team will be on-site at Booth 41 to share more about our AI-driven drug discovery technology.

Event registration is free of charge. For more information, please visit the official press release (link) and event website (link).